Suppr超能文献

大麻酚可预防 MDMA 对小鼠的神经毒性。

THC Prevents MDMA Neurotoxicity in Mice.

机构信息

Departament de Ciències Experimentals i de la Salut, Grup de Recerca en Neurobiologia del Comportament (GRNC), Universitat Pompeu Fabra, Barcelona, Spain.

出版信息

PLoS One. 2010 Feb 10;5(2):e9143. doi: 10.1371/journal.pone.0009143.

Abstract

The majority of MDMA (ecstasy) recreational users also consume cannabis. Despite the rewarding effects that both drugs have, they induce several opposite pharmacological responses. MDMA causes hyperthermia, oxidative stress and neuronal damage, especially at warm ambient temperature. However, THC, the main psychoactive compound of cannabis, produces hypothermic, anti-inflammatory and antioxidant effects. Therefore, THC may have a neuroprotective effect against MDMA-induced neurotoxicity. Mice receiving a neurotoxic regimen of MDMA (20 mg/kg x 4) were pretreated with THC (3 mg/kg x 4) at room (21 degrees C) and at warm (26 degrees C) temperature, and body temperature, striatal glial activation and DA terminal loss were assessed. To find out the mechanisms by which THC may prevent MDMA hyperthermia and neurotoxicity, the same procedure was carried out in animals pretreated with the CB(1) receptor antagonist AM251 and the CB(2) receptor antagonist AM630, as well as in CB(1), CB(2) and CB(1)/CB(2) deficient mice. THC prevented MDMA-induced-hyperthermia and glial activation in animals housed at both room and warm temperature. Surprisingly, MDMA-induced DA terminal loss was only observed in animals housed at warm but not at room temperature, and this neurotoxic effect was reversed by THC administration. However, THC did not prevent MDMA-induced hyperthermia, glial activation, and DA terminal loss in animals treated with the CB(1) receptor antagonist AM251, neither in CB(1) and CB(1)/CB(2) knockout mice. On the other hand, THC prevented MDMA-induced hyperthermia and DA terminal loss, but only partially suppressed glial activation in animals treated with the CB(2) cannabinoid antagonist and in CB(2) knockout animals. Our results indicate that THC protects against MDMA neurotoxicity, and suggest that these neuroprotective actions are primarily mediated by the reduction of hyperthermia through the activation of CB(1) receptor, although CB(2) receptors may also contribute to attenuate neuroinflammation in this process.

摘要

大多数摇头丸(迷幻药)娱乐性使用者也会吸食大麻。尽管这两种药物都有令人愉悦的效果,但它们会引起几种相反的药理反应。摇头丸会导致体温升高、氧化应激和神经元损伤,尤其是在温暖的环境温度下。然而,大麻的主要精神活性化合物四氢大麻酚会产生降温、抗炎和抗氧化作用。因此,四氢大麻酚可能对摇头丸引起的神经毒性具有神经保护作用。接受摇头丸(20mg/kg×4)神经毒性方案治疗的小鼠在室温(21°C)和温暖(26°C)下预先用四氢大麻酚(3mg/kg×4)预处理,并评估体温、纹状体神经胶质激活和 DA 末梢损失。为了找出四氢大麻酚预防摇头丸体温升高和神经毒性的机制,在预先用 CB1 受体拮抗剂 AM251 和 CB2 受体拮抗剂 AM630 以及 CB1、CB2 和 CB1/CB2 缺陷小鼠处理的动物中进行了相同的程序。四氢大麻酚预防了在室温下和温暖环境中饲养的动物中摇头丸引起的体温升高和神经胶质激活。令人惊讶的是,只有在温暖环境中饲养的动物才会观察到摇头丸引起的 DA 末梢损失,而这种神经毒性作用在给予四氢大麻酚后得到逆转。然而,在给予 CB1 受体拮抗剂 AM251 处理的动物中,四氢大麻酚既不能预防摇头丸引起的体温升高、神经胶质激活和 DA 末梢损失,也不能预防 CB1 和 CB1/CB2 基因敲除小鼠。另一方面,四氢大麻酚预防了摇头丸引起的体温升高和 DA 末梢损失,但仅部分抑制了给予 CB2 大麻素拮抗剂和 CB2 基因敲除动物的神经胶质激活。我们的结果表明,四氢大麻酚能预防摇头丸的神经毒性,并表明这些神经保护作用主要是通过激活 CB1 受体来降低体温而介导的,尽管 CB2 受体也可能有助于减轻这个过程中的神经炎症。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a56c/2824821/76d932167af7/pone.0009143.g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验